Chemcrux Enterprises Analysis

dividend

Pros

• Dividends paid are thoroughly covered by earnings (39.1x coverage).
• Chemcrux Enterprises's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
• Chemcrux Enterprises's dividend is above the markets top 25% of dividend payers in India (3.08%).

Cons

• Dividend payments have increased, but Chemcrux Enterprises only paid a dividend in the past 3 years.
• Whilst dividend payments have been stable, Chemcrux Enterprises has been paying a dividend for less than 10 years.

health

Pros

• Chemcrux Enterprises is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Chemcrux Enterprises is profitable, therefore cash runway is not a concern.
• Chemcrux Enterprises is profitable, therefore cash runway is not a concern.
• Debt is well covered by operating cash flow (503.5%, greater than 20% of total debt).
• Debt is covered by short term assets, assets are 18.2x debt.
• Chemcrux Enterprises's cash and other short term assets cover its long term commitments.
• The level of debt compared to net worth has been reduced over the past 5 years (49.8% vs 5.7% today).
• Interest payments on debt are well covered by earnings (EBIT is 80.2x coverage).
• Chemcrux Enterprises's level of debt (5.7%) compared to net worth is satisfactory (less than 40%).

Cons

• High level of physical assets or inventory.

management

Pros

• The average tenure for the Chemcrux Enterprises board of directors is over 10 years, this suggests they are a seasoned and experienced board.
• Sanjaybhai Yashwant's remuneration is lower than average for companies of similar size in India.
• Sanjaybhai Yashwant's compensation has been consistent with company performance over the past year, both up more than 20%.

Cons

misc

Pros

Cons

• Chemcrux Enterprises is not covered by any analysts.
• Chemcrux Enterprises's last earnings update was 215 days ago.
• Chemcrux Enterprises has significant price volatility in the past 3 months.

past

Pros

• Chemcrux Enterprises's 1-year earnings growth exceeds its 5-year average (59.3% vs 51.2%)
• Chemcrux Enterprises has delivered over 20% year on year earnings growth in the past 5 years.
• Chemcrux Enterprises used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
• Chemcrux Enterprises has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
• Chemcrux Enterprises has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
• Chemcrux Enterprises's earnings growth has exceeded the IN Chemicals industry average in the past year (59.3% vs 9.1%).

Cons

value

Pros

• Chemcrux Enterprises's share price is below the future cash flow value, and at a moderate discount (> 20%).
• Chemcrux Enterprises is good value based on earnings compared to the IN Chemicals industry average.
• Chemcrux Enterprises is good value based on earnings compared to the India market.
• 540395 outperformed the Market in India which returned -14.5% over the past year.
• BSE:540395 is up 11.8% outperforming the Chemicals industry which returned 6.9% over the past month.
• BSE:540395 is up 11.8% outperforming the market in India which returned 8% over the past month.

Cons

• Chemcrux Enterprises's share price is below the future cash flow value, but not at a substantial discount (< 40%).
• Chemcrux Enterprises is overvalued based on assets compared to the IN Chemicals industry average.
• 540395 underperformed the Chemicals industry which returned 2.2% over the past year.